Research programme: antimicrobial peptides - Omnix Medical
Alternative Names: OMN-50; OMN-70Latest Information Update: 23 Nov 2022
At a glance
- Originator Omnix Medical
- Class Antibacterials; Cyclic peptides
- Mechanism of Action Bacterial outer membrane protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections